Blog
FAQ Category: MPEP 2147 – Biotechnology Process Applications; Pre – Aia 35 U.S.C. 103(B)
-
How does one make a timely election to proceed under pre-AIA 35 U.S.C. 103(b)?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
What are the requirements for applying pre-AIA 35 U.S.C. 103(b)?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
What is pre-AIA 35 U.S.C. 103(b) and when does it apply?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
How has the Federal Circuit’s decisions in Ochiai and Brouwer affected the need for pre-AIA 35 U.S.C. 103(b)?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
What happens if a patent is granted without an election under pre-AIA 35 U.S.C. 103(b)?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
What is considered a “biotechnological process” under pre-AIA 35 U.S.C. 103(b)?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
Thirty minutes. Chief IP Officer on retainer — and the capital option behind it.
If what you need is something else, we’ll tell you on the same call.